ALLERGAN AMO ARRAY FOLDABLE INTRAOCULAR LENS SHOULD BE APPROVED AS BIFOCAL IOL CONTINGENT ON LABELING CHANGES, OPHTHALMIC PANEL SAYS IN 10-1 VOTE
This article was originally published in The Gray Sheet
Executive Summary
Allergan's AMO Array model SA40N posterior chamber intraocular lens should be designated "bifocal" instead of "multifocal," FDA's Ophthalmic Devices Panel said July 10 in recommending approval of the IOL contingent on several labeling changes.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.